Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer
Sunday, November 22, 2009 - 17:07
in Biology & Nature
Cambridge, MA -- November 23, 2009 -- Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene.